Quarterly report pursuant to Section 13 or 15(d)

Recapitalization - Schedule of Net current assets (Details)

v3.23.2
Recapitalization - Schedule of Net current assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Sep. 16, 2022
Jun. 30, 2022
Cash and cash equivalents $ 115,442 $ 167,467   $ 59,064
Marketable securities $ 28,540 $ 34,837    
Tyme Therapeutics, Inc.        
Cash and cash equivalents     $ 14,898  
Marketable securities     52,220  
Prepaid expenses     1,350  
Total     $ 68,468